Literature DB >> 9558397

Expression of the T-cell-specific tyrosine kinase Lck in normal B-1 cells and in chronic lymphocytic leukemia B cells.

M B Majolini1, M M D'Elios, P Galieni, M Boncristiano, F Lauria, G Del Prete, J L Telford, C T Baldari.   

Abstract

Src family kinases play a key role in mitogenesis. The exquisitely tissue-specific distribution of different Src family members suggests that a fine tuning of their expression might be a key prerequisite for cell homeostasis. We tested B cells from patients affected by B-cell chronic lymphocytic leukemia (B-CLL) for expression of Src family kinases. The T-cell-specific tyrosine kinase Lck was found to be expressed at significant levels in CLL B-cells. This finding could be accounted for either by ectopic expression of Lck in B-CLL or by specific expression of this kinase in normal B-1 cells, which are believed to be the normal counterpart of CLL B cells. To answer this question B cells from different sources, characterized by a different size of the B-1 subpopulation, were tested for Lck expression. The results show that Lck expression is a feature of CD5(+), B-1 cells, suggesting a potential role for Lck in the self-renewal capacity of this B-cell subpopulation and supporting the notion that B-1 cells are the subset undergoing oncogenic transformation in B-CLL. Furthermore, we show that the CD5(-), B-2 subpopulation, while normally lacking Lck expression, acquires the capacity to express Lck ectopically upon transformation by EBV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558397

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR.

Authors:  Stephanie C Casey; Edward L Nelson; Gina M Turco; Matthew R Janes; David A Fruman; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2011-03-24

Review 2.  Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?

Authors:  John C Allen; Fatima Talab; Joseph R Slupsky
Journal:  Int J Hematol Oncol       Date:  2016-05-26

3.  Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling.

Authors:  Efthymia Theofani; Spyridon Alexis; Paul Costeas; Christos Andriopoulos; Georgia Feleskoura; Panagiotis Zikos; Anthi Aktypi; Alexandros Spyridonidis; Konstantina Nika
Journal:  Blood Adv       Date:  2018-04-24

4.  Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma.

Authors:  Gaofeng Fan; Matthew J Simmons; Sheng Ge; Jui Dutta-Simmons; Jérôme Kucharczak; Yacov Ron; David Weissmann; Chiann-Chyi Chen; Chandreyee Mukherjee; Eileen White; Céline Gélinas
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

5.  Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.

Authors:  M W Harr; P F Caimi; K S McColl; F Zhong; S N Patel; P M Barr; C W Distelhorst
Journal:  Cell Death Differ       Date:  2010-03-19       Impact factor: 15.828

6.  The steroid and xenobiotic receptor negatively regulates B-1 cell development in the fetal liver.

Authors:  Stephanie C Casey; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2012-04-11

7.  SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.

Authors:  Nili Dezorella; Ben-Zion Katz; Mika Shapiro; Aaron Polliack; Chava Perry; Yair Herishanu
Journal:  Haematologica       Date:  2016-07-21       Impact factor: 9.941

8.  Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells.

Authors:  Rebekah L Browning; William H Byrd; Nikhil Gupta; Jeffrey Jones; Xiaokui Mo; Erin Hertlein; Lianbo Yu; Natarajan Muthusamy; John C Byrd
Journal:  Cancer Immunol Res       Date:  2016-06-10       Impact factor: 11.151

9.  A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer.

Authors:  S Hernández-Prieto; A Romera; M Ferrer; J L Subiza; J A López-Asenjo; J R Jarabo; A M Gómez; Elena M Molina; J Puente; J L González-Larriba; F Hernando; B Pérez-Villamil; E Díaz-Rubio; J Sanz-Ortega
Journal:  Clin Transl Oncol       Date:  2014-10-10       Impact factor: 3.405

10.  Lymphocyte-Specific Protein Tyrosine Kinase (LCK) is Involved in the Aryl Hydrocarbon Receptor-Mediated Impairment of Immunoglobulin Secretion in Human Primary B Cells.

Authors:  Jiajun Zhou; Qiang Zhang; Joseph E Henriquez; Robert B Crawford; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2018-10-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.